SHPH Shuttle Pharmaceuticals Holdings Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SHPH

Price (delayed)

$0.4301

Market cap

$7.22M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.44

Enterprise value

$5.73M

Highlights
The net income has dropped by 118% year-on-year and by 16% since the previous quarter
Shuttle Pharmaceuticals Holdings's EPS has plunged by 52% YoY and by 13% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of SHPH
Market
Shares outstanding
16.79M
Market cap
$7.22M
Enterprise value
$5.73M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.7
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$4.1M
EBITDA
-$4.09M
Free cash flow
-$5.6M
Per share
EPS
-$0.44
Free cash flow per share
-$0.38
Book value per share
$0.25
Revenue per share
$0
TBVPS
$0.4
Balance sheet
Total assets
$5.95M
Total liabilities
$1.9M
Debt
$1.09M
Equity
$4.06M
Working capital
$4.55M
Liquidity
Debt to equity
0.27
Current ratio
5.37
Quick ratio
5.24
Net debt/EBITDA
0.36
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-80.9%
Return on equity
-112.2%
Return on invested capital
-115.7%
Return on capital employed
-83.5%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SHPH stock price

How has the Shuttle Pharmaceuticals Holdings stock price performed over time
Intraday
0.02%
1 week
10.28%
1 month
0.02%
1 year
-68.49%
YTD
-5.47%
QTD
5.94%

Financial performance

How have Shuttle Pharmaceuticals Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$5.89M
Net income
-$6.59M
Gross margin
N/A
Net margin
N/A
Shuttle Pharmaceuticals Holdings's operating income has shrunk by 131% YoY and by 10% QoQ
The net income has dropped by 118% year-on-year and by 16% since the previous quarter

Growth

What is Shuttle Pharmaceuticals Holdings's growth rate over time

Valuation

What is Shuttle Pharmaceuticals Holdings stock price valuation
P/E
N/A
P/B
1.7
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Shuttle Pharmaceuticals Holdings's EPS has plunged by 52% YoY and by 13% from the previous quarter
Shuttle Pharmaceuticals Holdings's equity has decreased by 47% YoY and by 28% QoQ
The P/B is 19% lower than the last 4 quarters average of 2.1

Efficiency

How efficient is Shuttle Pharmaceuticals Holdings business performance
SHPH's return on equity is down by 33% since the previous quarter and by 9% year-on-year
The ROA fell by 25% QoQ and by 21% YoY
The company's return on invested capital rose by 17% QoQ

Dividends

What is SHPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SHPH.

Financial health

How did Shuttle Pharmaceuticals Holdings financials performed over time
SHPH's total liabilities has soared by 94% year-on-year and by 7% since the previous quarter
Shuttle Pharmaceuticals Holdings's current ratio has decreased by 39% YoY and by 38% QoQ
The debt is 73% lower than the equity
The company's debt to equity has surged by 170% YoY and by 59% QoQ
Shuttle Pharmaceuticals Holdings's equity has decreased by 47% YoY and by 28% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.